Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cattail pollen (蒲黄; Pu Huang) is the dried pollen of plants from the genus Typha (notably Typha angustifolia and Typha orientalis), used in Traditional Chinese Medicine (TCM) for over 2,000 years. It is classified as an herb that stops bleeding and moves blood to relieve stasis. The main active constituents are flavonoids such as isorhamnetin-3-O-β-D-galactoside and typhaloside. Cattail pollen exhibits hemostatic (stops bleeding), anti-inflammatory, analgesic (pain-relieving), diuretic, cardiotonic and astringent properties. It is primarily indicated for traumatic bleeding (including nosebleeds and wounds), abnormal uterine or menstrual bleeding, chest or abdominal pain due to blood stasis, hematuria (blood in urine), painful urination ("stranguria"), postpartum hemorrhage and trauma-related swelling or pain. In TCM it enters the Liver and Pericardium meridians with a sweet-neutral nature[1][2][4][5]. Modern research suggests potential cardiovascular protective effects due to its high flavonoid content[1]. Topical use includes application on wounds or ulcers mixed with honey.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cattail pollen.